Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004364 · ClinicalTrials.gov registry record
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
A clinical trial of First Episode Psychosis, sponsored by Northwell Health.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT04004364: Recruiting study of First Episode Psychosis, sponsored by Northwell Health.
NCT04004364 is a study of First Episode Psychosis that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 700 participants, below the 6,345-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04004364, a study of First Episode Psychosis, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.
Primary Outcome
Number of enrolled participants into the learning health system
Conditions Studied
Interventions
- OTHER Coordinated Specialty Care (CSC)
Study Locations (1)
Florida
- Henderson Behavioral Health - Lauderdale Lakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2025-03-31 |
What NCT04004364 shows while recruiting
NCT04004364 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 6,345-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (89% lower).
The record links to 1 condition, with First Episode Psychosis appearing as the primary indexed condition, and to 1 intervention - of which Coordinated Specialty Care (CSC) is the first listed.
NCT04004364 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04004364 about?
NCT04004364 is a clinical study titled "Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes". The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.
What is the current status of trial NCT04004364?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2020-04-01. Estimated completion is 2025-03-31.
What conditions does trial NCT04004364 study?
This clinical trial studies the following conditions: First Episode Psychosis.
What interventions are being tested in trial NCT04004364?
The interventions under investigation include: Coordinated Specialty Care (CSC) (OTHER).
Who is sponsoring clinical trial NCT04004364?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04004364 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for First Episode Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04004364's enrollment target sits among peer trials
700 3rd of 8 higher than 6 of 8 other First Episode Psychosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other First Episode Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot RCT of Self-stigma Treatment for First Episode Psychosis
RECRUITING · NA
-
Digital Strategies to Advance Help-Seeking Aim 1 and 2
RECRUITING
-
Digital Strategies to Advance Help-Seeking - Aim 3
RECRUITING · NA
-
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
RECRUITING · Phase 4
-
Artificial Intelligence to Measure Adherence to Oral Medication
RECRUITING · Phase 4
-
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI